Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNIK | Q9UKE5 | 2/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23985259 | 0.87 | MKNK2 (0.38) | TNIKJAK2MAPTKITKDM4E | |
| SCHEMBL30305429 | 0.84 | TNIK (0.40) | TNIKJAK2MAPTKDM4EHKDC1 | |
| SCHEMBL30305418 | 0.84 | TNIK (0.40) | TNIKJAK2MAPTKDM4EHKDC1 | |
| SCHEMBL30305407 | 0.84 | JAK2 (0.42) | TNIKJAK2MAPTKDM4EHKDC1 | |
| SCHEMBL23985262 | 0.84 | TNIK (0.40) | TNIKJAK2MAPTKDM4EHKDC1 | |
| SCHEMBL23985261 | 0.84 | JAK2 (0.42) | TNIKJAK2MAPTKDM4EHKDC1 | |
| SCHEMBL26712647 | 0.83 | MAPT (0.39) | MAPTKDM4EHKDC1 | |
| SCHEMBL23985903 | 0.81 | NTRK1 (0.36) | — | |
| SCHEMBL30305463 | 0.77 | TNIK (0.39) | TNIKJAK2MAPT | |
| SCHEMBL23985120 | 0.77 | TNIK (0.39) | TNIKJAK2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230353959-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230353959-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2023-11-02 | — | — | US | disclosed |
| WO-2021222556-A1 | PI3K-α INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |